HIT

Over the past six months, Health In Tech's share price has underperformed the S&P500 Index by approximately -50.5% to -50.72%. The stock's 52-week range has been between $0.56 and $4.02. Key events include the announcement of strong Q3 2025 financial results, the appointment of a Chief Growth Officer and Chief Technology Officer, a strategic collaboration with Ciklum and AWS, and the announcement of Q4 and full-year 2025 financial results, which missed Q4 earnings expectations and led to a stock decline. The company also announced and closed a $7.0 million private placement, filed for a 5.6 million share offering, and announced its participation in investor summits and the release date for its Q1 2026 financial results.